The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Mario Negri Institute for Pharmacological Research
Via Gavazzeni, 11
The Instituto di Ricerche Farmacologiche Mario Negri (Mario Negri Institute for Pharmacological Research) in Ranica, Italy, is a not-for-profit foundation established in 1963. The center operates on three levels: the Clinical Research Center, the Information Center for Rare Diseases, and the European School for Rare Diseases. The Clinical Research Center is a fully equipped hospital devoted entirely to clinical research. The aim is to develop research projects with special emphasis on rare diseases and innovative diagnostic and therapeutic procedures. The Information Center for Rare Diseases is a service to the public that provides up-to-date information on rare disorders with emphasis on causes, genetics, prevention, and investigational treatments of these disorders. The goal of the center is to create a computerized rare disease database containing updated information on rare disorders and a directory of specialized physicians and clinical research centers in Europe that are familiar with a variety of rare diseases. The European School for Rare Diseases functions as a forum for cultural activities aimed at specialists and health professionals. Workshops and conferences are scheduled throughout the year. Clinical training includes short "basic" courses, intensive courses, and clinical research studies.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.